Garcia, Rodrigue <br/><br/>
Subcutaneous cardioverter defibrillator has longer time to therapy but is less cardiotoxic than transvenous cardioverter defibrillator. Study carried out in a preclinical porcine model.  [electronic resource] 

 -  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology  05 2018 
 - 873-879 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1532-2092 
<br/><br/><label>Standard No.: </label>10.1093/europace/eux074  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Creatine Kinase--analysis<br/>Defibrillators, Implantable--adverse effects<br/>Disease Models, Animal<br/>Electric Countershock--adverse effects<br/>Equipment Design<br/>Swine<br/>Treatment Outcome<br/>Troponin T--analysis<br/>Ventricular Fibrillation--therapy